NHSN Long-Term Care COVID-19 Module — CDC’s National Healthcare Safety Network (NHSN) added a Point of Care Laboratory Reporting Pathway within the NHSN Long-Term Care COVID-19 Module. This added capability enables CMS-certified long-term care facilities to meet the Department of Health and Human Services’ requirement to report SARS-CoV-2 point-of-care antigen test data, and other on-site COVID-19 laboratory testing data.
The HHS guidance states: "CMS-certified long-term care facilities shall submit point-of-care SARS-CoV-2 testing data, including antigen testing data, to CDC’s National Healthcare Safety Network (NHSN). This requirement to submit data to CDC’s NHSN applies only to CMS-certified long-term care facilities. Test data submitted to NHSN will be reported to appropriate state and local health departments using standard electronic laboratory messages. Other types of LTC facilities may voluntarily report testing data in NHSN for self-tracking or to fulfill state or local reporting requirements, if any."
The new NHSN pathway creates a single, standardized reporting system:
· that all ~15,400 nursing homes already use for other mandatory COVID-19 reporting;
· has the capability to share data with state and local health departments;
· has the ability to share data with HHS and CMS; and
· avoids the creation of a patchwork of different jurisdictional reporting systems by state health departments.
In order to utilize the new pathway to fulfill reporting requirements, nursing homes and other long-term care facilities that are NHSN users will need to upgrade their NHSN Secure Access Management Service (SAMS) from Level 1 to Level 3. CDC is working closely with facilities to assist them in this process. An email invitation from CDC to perform this upgrade will be sent to users. Alternatively, facilities can email firstname.lastname@example.org with the subject line “Enhancing Data Security” to begin upgrading their SAMS access to use this Pathway.
Guidance for SARS-CoV-2 Point-of-Care Testing — Point-of-care (POC) tests, such as some rapid tests for diagnosing an infectious disease, provide results within minutes of the test being administered, allowing for rapid decisions about patient care. POC tests can also extend testing to communities and populations that cannot readily access care. This page provides detailed information on the following:
· Overview of POC testing
· How to obtain a Clinical Laboratory Improvement Amendments (CLIA) certificate
· How to safely perform POC specimen collection, handling, and testing for COVID-19
· How to comply with result reporting requirements
To learn more, please visit: Guidance for SARS-CoV-2 Point-of-Care Testing